Carotid
CAS

The role of MicroNet-covered carotid stents in the post-CREST-2 world

Discover the latest updates in carotid artery stenting in this PVI 2025 symposium replay.

The session follows the case of a 71-year-old woman who suffered a right-hemispheric stroke 11 months earlier, illustrating how CREST-2 trial outcomes inform real-world clinical decisions.

Experts discuss the clinical performance of MicroNET-covered stents (CGuard, InspireMD), highlighting evidence from the PARADIGM trial, the C-GUARDIANS study, and FDA-IDE trials

Learn how these stents can be applied in carotid artery stenting (CAS), carotid endarterectomy (CEA), transcarotid artery revascularisation (TCAR), and imaging-guided interventions to enhance procedural safety and optimize patient outcomes.

Watch the full session to explore evolving strategies and see how advanced stent technologies are shaping carotid revascularisation today.

John Paul II Hospital, Poland
video

This session was supported by InspireMD

InspireMD